CDC Models Show Scaling Up ART For HIV Treatment Can Save Money Over Time
Monday, January 30, 2012
During a webinar Thursday hosted by the Health Global Access Project, AVAC, and amfAR (The Foundation for AIDS Research), John Blandford, chief of CDC's Division of Global HIV/AIDS Health Economics, Systems and Integration Branch, presented findings showing "that scaling up antiretroviral therapy (ART) for HIV/AIDS treatment and prevention in the developing world not only saves lives, but saves money too," the Center for Global Health Policy's "Science Speaks" blog reports. According to the blog, "[Blandford] and his team of colleagues have found that cost savings from averted negative outcomes offset a major portion of the cost of treatment over time." The blog quotes Blandford saying, "Based on [WHO] standards, ART should be considered highly cost-effective in almost every country in sub-Saharan Africa" (Mazzotta, 1/27).
Print This ArticlePrint Entire Report
The Kaiser Daily Global Health Policy Report is published by the Kaiser Family Foundation. 2012 Henry J. Kaiser Family Foundation. All rights reserved. The report summarizes the latest, most relevant information on U.S. global health policy developments and related news from hundreds of sources. Access today's full report or sign up for an email subscription to the Daily Report.
